Personality isn't just about upbringing. It might also be written in our genes. A new look at 348 healthy people found surprising links between vitamin-related genetic scores and how we feel emotionally. Specifically, the study looked at neuroticism, which describes a tendency toward anxiety and moodiness. The results showed that genetic scores for vitamin B9 were linked to lower levels of neuroticism in women. In men, the opposite was true: genetic scores for vitamin D were linked to higher neuroticism. Interestingly, genetic scores for vitamin B9 showed no connection to neuroticism in men. The researchers also found that these vitamin scores were connected to genetic risks for bipolar disorder and alcohol use disorders in men. These findings suggest that the biological pathways for vitamins might work differently depending on sex. While this is a genetic study, not a trial, it highlights how our biology shapes who we are. The data comes from a group of unrelated individuals, meaning these results apply to a specific type of healthy population. We must remember that genetics are only one piece of the puzzle. Many other factors, like environment and life experiences, also shape our personalities. This research opens a window into how our bodies and minds are connected in ways we are only beginning to understand.
Vitamin D and B9 genetic scores linked to neuroticism in healthy adultsGenetic scores for vitamins B9 and D link to personality traits in men and women
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This was a cohort study of 348 healthy unrelated individuals in a nonclinical setting. The study assessed genetic polygenic scores (PGS) for vitamin D (VD) and vitamin B9 (VB9) concentrations and evaluated their association with neuroticism scores.
The main results showed a negative association between VB9-PGS and neuroticism scores in women. In men, there was a positive association between VD-PGS and neuroticism scores. For men, neuroticism scores were not correlated with PGS for neuroticism but were associated with PGS for bipolar disorder type 1 and alcohol use disorders. No effect sizes, absolute numbers, or p-values were reported for these associations.
Safety and tolerability data were not reported, as adverse events, serious adverse events, and discontinuations were not reported. Key limitations include the observational design, which cannot establish causation, and the lack of reported effect sizes, confidence intervals, or follow-up duration.
The practice relevance was not reported. The study aimed to evaluate associations, and results suggest effects of genetic propensity might differ across sexes, but clinical outcomes were not assessed.